Faysal A. Sohail - Net Worth and Insider Trading

Faysal A. Sohail Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Faysal A. Sohail owns 4 companies in total, including VYNE Therapeutics Inc (VYNE) , Neos Therapeutics Inc (NEOS) , and Intermolecular Inc (IMI) among others .

Click here to see the complete history of Faysal A. Sohail’s form 4 insider trades.

Insider Ownership Summary of Faysal A. Sohail

Ticker	Comapny	Transaction Date	Type of Owner
VYNE	VYNE Therapeutics Inc	2018-03-02	10 percent owner
NEOS	Neos Therapeutics Inc	2016-04-18	10 percent owner
IMI	Intermolecular Inc	2014-11-10	10 percent owner
		2013-09-18	10 percent owner

Faysal A. Sohail Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Faysal A. Sohail Ownership Network

Ownership Network List of Faysal A. Sohail

No Data

Ownership Network Relation of Faysal A. Sohail

Faysal A. Sohail Owned Company Details

What does VYNE Therapeutics Inc do?

Who are the key executives at VYNE Therapeutics Inc?

Faysal A. Sohail is the 10 percent owner of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .

VYNE Therapeutics Inc (VYNE) Insider Trades Summary

Over the past 18 months, Faysal A. Sohail made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

VYNE Therapeutics Inc Insider Transactions

No Available Data

What does Neos Therapeutics Inc do?

Who are the key executives at Neos Therapeutics Inc?

Faysal A. Sohail is the 10 percent owner of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , SVP & General Counsel John M Limongelli , and Chief Financial Officer Richard I Eisenstadt .

Neos Therapeutics Inc (NEOS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neos Therapeutics Inc Insider Transactions

No Available Data

What does Intermolecular Inc do?

Who are the key executives at Intermolecular Inc?

Faysal A. Sohail is the 10 percent owner of Intermolecular Inc. Other key executives at Intermolecular Inc include director & President and CEO Christian Kramer , 10 percent owner Irwin Federman , and 10 percent owner Raging Capital Management, Llc .

Intermolecular Inc (IMI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intermolecular Inc (IMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intermolecular Inc (IMI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intermolecular Inc (IMI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intermolecular Inc Insider Transactions

No Available Data

What does Tetraphase Pharmaceuticals Inc do?

Who are the key executives at Tetraphase Pharmaceuticals Inc?

Faysal A. Sohail is the 10 percent owner of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .

Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tetraphase Pharmaceuticals Inc Insider Transactions

No Available Data

Faysal A. Sohail Mailing Address

Above is the net worth, insider trading, and ownership report for Faysal A. Sohail. You might contact Faysal A. Sohail via mailing address: C/o Presidio Partners, 655 Montgomery Street, Suite 6-161, San Francisco Ca 94111.

Discussions on Faysal A. Sohail

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.